Balance In OND Offices' Staffing Drives CDER Reorganization - Jenkins
This article was originally published in The Tan Sheet
Executive Summary
The FDA Office of Nonprescription Products' capacity to be part of a larger unit was a factor in reorganizing ONP into an office that also includes medical imaging oversight, drug center executive John Jenkins says